secwatch.observer — SEC 8-K summary
======================================

Issuer:     HENRY SCHEIN INC (HSIC)
CIK:        0001000228
Form:       8-K
Filed at:   2023-12-18T23:59:59+00:00
Accession:  0001193125-23-297629
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Henry Schein appoints Carole T. Faig as independent director; board expands to 15
--------------------------------------------------------------------------------

- Carole T. Faig appointed effective Dec 13, 2023; will serve until 2024 annual meeting, expected to stand for re-election.
- Faig brings 38-year Ernst & Young career, most recently as U.S. Health Leader and West Region Health and Life Sciences Leader.
- Board increased size to 15 directors to fill vacancy; Faig is independent and chairs audit committees at three other companies.
- Amendment Number Four to Supplemental Executive Retirement Plan approved, effective Jan 1, 2024, allowing joint ventures 50%+ owned to participate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000228/000119312523297629/0001193125-23-297629-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000228/000119312523297629/d27795d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-297629

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer